Identification of differentially regulated proteins in metronidozole resistant Helicobacter pylori by proteome techniques

Citation
Cp. Mcatee et al., Identification of differentially regulated proteins in metronidozole resistant Helicobacter pylori by proteome techniques, PROTEOMICS, 1(4), 2001, pp. 516-521
Citations number
16
Categorie Soggetti
Chemistry & Analysis
Journal title
PROTEOMICS
ISSN journal
16159853 → ACNP
Volume
1
Issue
4
Year of publication
2001
Pages
516 - 521
Database
ISI
SICI code
1615-9853(200104)1:4<516:IODRPI>2.0.ZU;2-6
Abstract
Resistance to metronidazole (MTZ) is common among Helicobacter pylori strai ns in many societies, and results from loss of function mutations in genes for one or more cellular nitroreductases. When functional, these enzymes co nvert MTZ from a harmless prodrug to mutagenic and bacteriocidal products ( probably hydroxylamine-type compounds), and in the process may generate act ive reactive oxygen metabolites. Here we examine the protein profiles of a derivative of strain 26695 that is resistant to moderate levels of MTZ beca use of mutation in rdxA (HP0954), the gene for the most important of these nitroreductases. The strain was grown with and without 18 mug/mL of MTZ to assess whether sublethal exposure triggers an adaptive response. Bacterial lysates were subjected to two-dimensional (2-D) electrophoresis and protein bands were identified by mass spectrometry and sequence analysis. Several proteins were decreased at least two-fold during growth with MTZ, yet the l evels of various isoforms of alkylhydroperoxide reductase (AHP) (encoded by ahpC HP1563) were increased. AHP is an essential enzyme, and had been link ed to resistance to oxygen toxicity in various prokaryotic and eukaryotic s ystems; we propose that the ability of an rdxA mutant strain to increase AH P abundance during exposure to MTZ is critically important in the realizati on of the resistance phenotype. More generally, these results highlight the potential of proteome analysis to tracing out how pathogenic bacteria cope with the challenges imposed on them by therapy or host responses to infect ion.